Points to consider on the Reduction, elimination or substitution of thiomersal in vaccines
Concept paper on the development of a CPMP Points to Consider on biostatistical/methodological issues arising from CPMP discussions on li- censing applications: adjustment for baseline covariates Adoptée en février 2000